Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?
Purpose: Spinal muscular atrophy type 1 has a devastating natural course and presents a severe course marked by scoliosis and hip subluxation in nonambulatory patients. Nusinersen, Food and Drug Administration-approved spinal muscular atrophy therapy, extends survival and enhances motor function. Ho...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2024-06-01
|
| Serija: | Journal of Children's Orthopaedics |
| Online pristup: | https://doi.org/10.1177/18632521241235028 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|